Loading organizations...
Key people at Inevitable Ventures.
Inevitable Ventures primarily invests at the intersection of applied artificial intelligence (AI), robotics, and cyber-physical infrastructure. Their objective is to lay the foundation for the next industrial era by backing companies in these critical technology sectors.
Inevitable Ventures was founded by a notable group including billionaire investor Ron Burkle, prominent VC fund manager Chris Hollod, and recording artist David Wallach. This investment partnership leverages their diverse expertise and networks.
Inevitable Ventures operates as both a venture fund and an incubator, investing at the inception stage and co-building early products. Beyond capital, they provide network access, subject-matter expertise, and partner with leading hacker communities to support European founders and venture capitalists.
Inevitable Ventures demonstrates a strong focus on supporting founders and ventures across Europe, as indicated by their incubator activities and partnerships. While some sources suggest operations in the United States, their stated engagement often highlights the European startup ecosystem.
Inevitable Ventures primarily invests at the intersection of applied artificial intelligence (AI), robotics, and cyber-physical infrastructure. Their objective is to lay the foundation for the next industrial era by backing companies in these critical technology sectors.
Inevitable Ventures was founded by a notable group including billionaire investor Ron Burkle, prominent VC fund manager Chris Hollod, and recording artist David Wallach. This investment partnership leverages their diverse expertise and networks.
Inevitable Ventures operates as both a venture fund and an incubator, investing at the inception stage and co-building early products. Beyond capital, they provide network access, subject-matter expertise, and partner with leading hacker communities to support European founders and venture capitalists.
Inevitable Ventures demonstrates a strong focus on supporting founders and ventures across Europe, as indicated by their incubator activities and partnerships. While some sources suggest operations in the United States, their stated engagement often highlights the European startup ecosystem.
Inevitable Ventures is an early-stage venture capital firm based in Los Angeles, California, that invests opportunistically in radical emerging technologies addressing challenging problems across various sectors. Its investment scope covers diverse industries including healthcare, media, life sciences, financial services, food, logistics, Web3, consumer tech, and the creator economy. The firm primarily focuses on supporting visionary entrepreneurs within companies based in Southern California. Operating as a venture capital fund, it raises capital from partners to make early-stage investments. Notable portfolio investments include 8i, Upside Foods (formerly Memphis Meats), Thrive Market, and Picnic Health. Inevitable Ventures was founded by Chris Hollod, Ron Burkle, and D.A. Wallach. Its business model centers on venture capital fund raising capital from partners like billionaire investors to make early-stage investments in startups.
Inevitable Ventures is a Los Angeles-based investment partnership founded by billionaire investor Ron Burkle, VC fund manager Chris Hollod, and recording artist/investor D.A. Wallach. Its mission centers on supporting entrepreneurs tackling difficult problems in industries central to human life, such as healthcare, biotechnology, life sciences, financial services, food, logistics, media, e-commerce, and radical emerging technologies that create novel consumer experiences.[1][3][4][5] The firm's investment philosophy is opportunistic, focusing on breakthrough startups like Glympse Bio, Beam, Neuralink, Doctor on Demand, Devoted Health, and early bets on Spotify, SpaceX, and Ripple, with check sizes ranging from $500K to $10M across seed, Series A, and later rounds, primarily in the USA.[1][4][5] It has influenced the startup ecosystem through high-profile biotech and healthcare investments, achieving 2 portfolio exits including Glympse Bio in 2023, while providing targeted support for Southern California builders.[1][3][4]
A separate, newer entity named Inevitable Ventures, launched in 2025 and based in Bucharest, invests in early-stage European founders at the intersection of applied AI, robotics, and cyber-physical infrastructure; this analysis focuses on the primary LA firm given its established track record.[2]
Inevitable Ventures emerged from the converging expertise of its founders: Ron Burkle's billionaire investment acumen, Chris Hollod's VC management prowess, and D.A. Wallach's dual career as an acclaimed musician turned biotech-focused investor. Wallach shifted from touring in 2011 to VC, backing defining tech like Spotify and SpaceX before narrowing to biotech/healthcare since 2015 with investments in Neuralink and others.[1][4] The partnership formed to channel this blend into opportunistic bets on transformative tech, basing operations in Los Angeles with emphasis on local Southern California innovation; key early moves included 2016-2018 Series A/B investments like Glympse Bio ($22M round).[1][3][4]
Inevitable Ventures rides the wave of biotech and healthcare reinvention amid accelerating tech convergence with biology, fueled by AI-driven drug discovery and longevity advances. Timing aligns with post-2020 biotech boom, where firms like Neuralink push human augmentation and firms like Glympse enable real-time disease detection.[1][4] Market forces favoring them include rising VC interest in "moonshot" therapies, Southern California's emerging biotech hub status challenging SF/NY dominance, and founders' networks unlocking mega-deals.[1][3] The firm influences the ecosystem by validating high-risk bets, bridging entertainment/tech talent into science, and fostering LA as a nexus for life sciences innovation.[1][4]
Inevitable Ventures is poised to scale its biotech/healthcare focus amid AI-biotech synergies, potentially leading more Series A/B rounds in neurotech, precision medicine, and logistics automation. Trends like mRNA expansion (echoing portfolio pipelines) and cyber-physical systems will shape its path, with LA's growth amplifying influence.[1][2][4][5] As founders leverage personal brands for deal flow, expect evolving impact through exits and follow-ons, solidifying its role in human-life tech frontiers—echoing its core mission to back the inevitable.
Key people at Inevitable Ventures.
Inevitable Ventures has 4 tracked investments across 4 companies. The latest tracked deal is $100.0M Series B in Cambium in January 2026.
